• 137426+ Medical Conferences
  • 251 Specialties
  • 10509 Organizers
  • 151941 Speakers
  • 156 Countries
  • 4563 Cities
CME Conference Registrations Sold
Home  >  Conferences  >  Microbiome Movement - Maternal & Infant Health Summit

Microbiome Movement - Maternal & Infant Health Summit

May 22 - 24, 2019   |   Boston, Massachusetts  United States of America
Organized by : Hanson Wade
Conference Brochure

1st Microbiome Movement - Maternal & Infant Health Summit is organized by Hanson Wade and will be held from May 22 - 24, 2019 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

Conference Description:
Compared to the development of microbiome-based products for adult disease, microbial-derived solutions for the pediatric setting have long been ignored. More recently, however, research investigating how the early life microbiome predisposes various health outcomes in infants is seeing an injection of scientific interest and investment.

The inaugural Microbiome Movement - Maternal and Infant Health Summit has been established to improve your understanding of the fundamental maternal-infant microbiome mechanisms of action and advance translation of this causality into evidence-based and clinically validated therapeutic, nutritional and preventative solutions that will configure healthy foundations of the microbiome within the first 1000 days of life.

This first-of-its-kind event is your opportunity to learn from the expertise of key opinion leaders from large pharma, biotech and academic research institutes presenting the latest case studies and in-depth discussion on key topics including:

• Discovering the causal relationships between the maternal-infant microbiome and disease onset
• Exploring different therapeutic products that restore the infant microbiome, as well as treat and prevent disease
• Discussing study design for investigation of the microbiome in maternal and pediatric settings
• Understanding the role of the maternal microbiome in preterm birth and infant health outcomes
• Optimizing –omics and realizing how to integrate these data with novel pre-clinical modelling to generate clinically meaningful results
• Explaining regulatory processes for IND-approved products targeting maternal and infant populations
• Addressing public health, economic and educational considerations for commercializing microbiome-based products for mothers and infants

There is no question that the pre-, peri- and postnatal maternal and infant microbiomes are critical windows of opportunity, that need to be acted upon today.

Join us to unlock the therapeutic potential of the maternal-infant microbiome and proactively contribute to healthier clinical outcomes in new-borns brought into the world tomorrow.

Early booking and group discounts apply, start-up and academic rates are available - see the website for details.

Pre-Conference Workshop on May 22, 2019
Main Conference From May 23 - 24, 2019

Speakers: Alessio Fasano, Professor and Director Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Aurélien Baudot, International Business Development, ProDigest, Ben Callahan, Assistant Professor, NC State University, Bethany Henrick, Director, Immunology and Diagnostic, Evolve Biosystems, Cathryn Nagler, Bunning Food Allergy Professor, University of Chicago, John Colson, Director of Operations, ClostraBio, David Kyle, Executive Chairman and CSO, Evolve BioSystems, Deshanie Rai, Associate Adjunct Professor, Friedman School of Nutrition Science and Policy - Tufts University, Jeff Roberts, Medical Officer, Division of Vaccines and Related Product Applications, OVRR/CBER/FDA, Joseph Petrosino, CEO, Diversigen, Keith Martinez, Postdoctoral Fellow, Dominguez-Bello Lab, Rutgers University, Mark Heiman, CSO, Scioto Biosciences, Meghan Azad, Assistant Professor, Pediatrics and Child Health, University of Manitoba, Nitya Jain, Principal Investigator, Harvard Medical School, Noah Voreades, Consultant, GenBiome Consulting, Ryan Pace, Post-Doctoral Associate, Aagaard Lab, Baylor College of Medicine, Staffan Stromberg, CEO, Infant Bacterial Therapeutics, Tuval Ben-Yehezkel, CEO, Loop Genomics

Time: 7:30 am - 5:15 pm

View All Speaking

Alessio Fasano
Alessio Fasano


David Kyle
David Kyle

Biochemistry and Molecular Genetics

Cathryn R. Nagler
Cathryn R. Nagler


Benjamin John Callahan
Benjamin John Callahan

Immunology and Microbiology

Registration Desk

Contact No. : +1 617 455 4188

View Expired Tickets
view all
  • Drive Walk Transit Bicycle

Venue Address

Revere Hotel Boston Common
200 Stuart St
Boston, Massachusetts, United States of America

Plan Your Travel


Please Rate this Conference


Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Freepoint Hotel Cambridge, Tapestry Collection by Hilton
4.66 miles from venue
Price : USD 259.00 Per Night
The Charles Hotel in Harvard Square
3.16 miles from venue
Price : USD 649.00 Per Night
Encore Boston Harbor
3.08 miles from venue
Price : USD 0.00 Per Night
Hilton Boston Logan Airport
2.55 miles from venue
Price : USD 207.00 Per Night

Session Details

Session Topic Start Time End Time Location Description Speakers

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter


Subscribe to our newsletter and receive updates on medical conferences, board review courses and news